Drugs / IS045-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02496845 | Aug → Nov 2015 | erectile dysfunction | VasoLead (2012) Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IS045-01 | “Topical treatment and PK. Administration of VL#FIA3-30 (dual administration of MH30-01 \& IS045-01)” NCT02496845 ↗ |